Infoterra was founded in 2001, six years before TerraSAR-X launched, specifically to build a commercial market for radar satellite data. It was a subsidiary of EADS Astrium, Europe’s third-largest space company at the time, operating within a corporation of 116,000 employees and €39 billion in revenues. The resources were there. The technology was there. The structural problem was also there.
Commercial SAR data in the mid-2000s had no established non-defence commercial buyer. The primary customers were military and government agencies – and within that segment, SAR data reached users through institutional frameworks such as the International Charter on Space and Major Disasters, which is activated free of charge for emergency response organisations following qualifying events. But that was not a commercial market. It was a gratis activation system for state actors. The corporate or insurance buyer who would later pay for persistent SAR monitoring did not yet exist.
Infoterra built a global distribution network of around 60 resellers, but the radar data market was largely unfamiliar territory for most of them. Optical imagery was cheaper, easier to understand, and already had established workflows. Convincing buyers to work with radar data required education, customised processing pipelines, and applications development – all of which took time and money that a single satellite with a finite operational life could not absorb.
The economics of data access compounded the problem. Direct reception of TerraSAR-X data required a special terminal for ground station infrastructure that came at a significant cost – a barrier that pushed time-sensitive buyers toward alternatives. MDA’s RADARSAT offered a more accessible entry point for clients who needed speed of delivery over imagery parameters.
While Infoterra was still building its single-satellite commercial case, COSMO-SkyMed launched its first satellite in June 2007, the same month as TerraSAR-X. Backed by the Italian Space Agency (ASI) and the Italian Ministry of Defence, COSMO-SkyMed benefited from a more institutionally supported market-entry environment and from a faster-emerging constellation logic. By late 2008, it had three satellites in orbit, and by November 2010, a full four-satellite constellation with revisit times under 12 hours. For buyers not yet ready to pay for unfamiliar data, that combination of institutional backing and constellation capacity was decisive.
The model was also structurally constrained: one satellite (later two with TanDEM-X, but designed around a shared mission profile), exclusive rights, premium pricing, and corporate overhead. Infoterra operated as a business unit within a defence and aerospace giant, for which it accounted for a small fraction of revenue. The commercial EO market was not yet large enough, mature enough, or fast enough to justify the scale of investment required, and there was no path to build a constellation within that structure. When Astrium merged with Cassidian and Airbus Military in early 2014 to form Airbus Defence and Space, Infoterra’s capabilities were absorbed. The bet on commercial SAR as a standalone business did not pay off – not because the technology failed, but because the market development cycle outlived the satellite’s commercial window.